In contrast to APP overexpression models, APPKI mice display a higher Aβ42/Aβ40 ratio as well as amyloid plaque sizes and neuroinflammatory responses comparable to AD patients (Saito et al., 2014; Saito and Saido, 2018). The gene discussed is APP; the disease is Alzheimer disease.